Finally, using NT-proBNP for outpatient screening of high-risk but asymptomatic individuals-such as those with hypertension, diabetes, or obesity-may aid in identifying pre-HFpEF earlier and facilitating timely intervention [26,27]. Here, NPPB is linked to obesity due to melanocortin 4 receptor deficiency.